Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China: Duloxetine Versus Placebo.

Trial Profile

Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China: Duloxetine Versus Placebo.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 May 2015

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 06 Jun 2013 Planned End Date changed from 1 Sep 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top